Market Closed

MGNX
MacroGenics
$ 2.20
-3.93%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

MacroGenics News

Latest MacroGenics Stock News & MGNX Headlines

MacroGenics (MGNX) Reports Q3 Loss, Lags Revenue Estimates
2 days ago | zacks.com
MacroGenics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate Progress
3 days ago | globenewswire.com
MacroGenics Announces Appointments of Emil Kuriakose, M.D., and Michael Vasconcelles, M.D.
12 days ago | globenewswire.com
MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer
20 days ago | globenewswire.com
MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN
23 days ago | globenewswire.com
MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
a month ago | globenewswire.com
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
a month ago | zacks.com
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2 months ago | globenewswire.com
MacroGenics: Inexpensive ADC/TCE Biotech With Multiple Catalysts Ahead
2 months ago | seekingalpha.com
Bank of America Corp DE Buys 564,094 Shares of MacroGenics, Inc. $MGNX
3 months ago | defenseworld.net
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

MGNX
MacroGenics
$ 2.20
-3.93%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago